Funding

The Whiteley Lab gratefully acknowledges support from the following funders:

Funder:ÌýTheÌýBurroughs Welcome Fund

Program:ÌýInvestigators in the Pathogenesis of Infectious Disease (PATH)​ Award

The Ìýis highly competitive and provides funding to study pathogenesis: the points where the systems of humans and potentially infectious agents connect. The program givesÌýrecipients the freedom and flexibility to pursue new avenues of inquiry, stimulating higher-risk research projects that hold potential for significantly advancing our understanding of how infectious diseases work and how health is maintained. Whiteley is one of 8Ìýscientists in 2024 that received a grant of $500,000 over five years.

  • Ìýfrom The Burroughs Welcome Fund
  • Full list of PATH recipientsÌý

Funder:ÌýThe Pew Charitable Trusts

Program:ÌýPew Scholars Program in the Biomedical Sciences

The provides funding to young investigators of outstanding promise in science relevant to the advancement of human health. The program makes grants to selected academic institutions to support the independent research of outstanding individuals who are in their first few years of their appointment at the assistant professor level. Whiteley is one of 22 early career scientists in 2023 that received $300,000 over four years to spearhead innovative studies exploring human health and medicine.

  • Read the storyÌýin theÌýÃÛÌÇÖ±²¥ Arts and Sciences Magazine
  • Ìýfrom The Pew Charitable Trusts
  • Pew Scholars Directory

Funder:ÌýNational Institutes of Health (NIH) Office of the Director (OD), NIH Common Fund, and NIH National Center For Complementary & Integrative Health (NCCIH)

Program:ÌýNIH Director’s New Innovator Award Program (DP2)

Grant number:ÌýDP2AT012346

TheÌýÌýsupportsÌýexceptionally creative early career investigatorsÌýwho proposeÌýinnovative, high-impact projectsÌýin the biomedical, behavioral or social sciences within the NIH mission. Our work is onÌýDeciphering the crosstalk between bacteria and their mammalian hosts​. Each awardee will receiveÌýa grant of $1,500,000 in direct costs over five years.

  • Read the story in theÌýÃÛÌÇÖ±²¥ Arts and Sciences Magazine
  • from the NIH
  • NIH RePorter

Ìý

AB Nexus Grant Program

Funder:ÌýUniversity of ÃÛÌÇÖ±²¥

Program:ÌýAB Nexus Grant Program

The AB Nexus Grant Program supports collaborative research between ÃÛÌÇÖ±²¥ Boulder and ÃÛÌÇÖ±²¥ Anschutz Medical School campuses. Our work is onÌýNucleotide Second Messengers at the Host-Pathogen Interface, in collaboration with Dr.ÌýKelly S. Doran, PhD, (Department of Immunology and Microbiology), ÃÛÌÇÖ±²¥ Anschutz. Each AB Nexus grantee team will receiveÌýa $50,000 grant over 18 months.

  • Read the story in theÌýÃÛÌÇÖ±²¥ Arts and Sciences Magazine
  • ÌýfromÌýÃÛÌÇÖ±²¥ Anschutz Medical Campus

Funder:ÌýBoettcher Foundation

Program:ÌýWebb-Waring Biomedical Research Awards Program

The has named Aaron and 7 others to the 2022 class of Boettcher Investigators through theÌýBoettcher Foundation’s Webb-Waring Biomedical Research Awards Program.ÌýThe prestigious award supports promising, early career scientific researchers, allowing them to advance their independent research in ÃÛÌÇÖ±²¥ and compete for major federal and private awards in the future. Each Boettcher Investigator will receive a $235,000 grant to support up to three years of biomedical research.

  • Read the story in theÌýÃÛÌÇÖ±²¥ Arts and Sciences Magazine
  • Ìýfrom the University of ÃÛÌÇÖ±²¥

Funder:ÌýMallinckrodt Foundation

Program:ÌýMallinckrodt Foundation Grant

The supports early-stage biomedical investigators engaged in basic and translational research that has the potential to make fundamental advances in biomedical science. Each grantee receives a $180,000 grant to support three years of biomedical research.